IMRX
Price
$3.59
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
124.15M
31 days until earnings call
ORMP
Price
$2.18
Change
+$0.02 (+0.93%)
Updated
Jul 3 closing price
Capitalization
89.05M
38 days until earnings call
Interact to see
Advertisement

IMRX vs ORMP

Header iconIMRX vs ORMP Comparison
Open Charts IMRX vs ORMPBanner chart's image
Immuneering
Price$3.59
Change-$0.00 (-0.00%)
Volume$25.3K
Capitalization124.15M
Oramed Pharmaceuticals
Price$2.18
Change+$0.02 (+0.93%)
Volume$18.03K
Capitalization89.05M
IMRX vs ORMP Comparison Chart in %
Loading...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRX vs. ORMP commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRX is a Hold and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (IMRX: $3.45 vs. ORMP: $2.18)
Brand notoriety: IMRX and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRX: 64% vs. ORMP: 25%
Market capitalization -- IMRX: $124.15M vs. ORMP: $89.05M
IMRX [@Biotechnology] is valued at $124.15M. ORMP’s [@Biotechnology] market capitalization is $89.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRX’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • IMRX’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, IMRX is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRX’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 3 bullish TA indicator(s).

  • IMRX’s TA Score: 4 bullish, 4 bearish.
  • ORMP’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, IMRX is a better buy in the short-term than ORMP.

Price Growth

IMRX (@Biotechnology) experienced а +8.15% price change this week, while ORMP (@Biotechnology) price change was +0.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

IMRX is expected to report earnings on Nov 06, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMRX($124M) has a higher market cap than ORMP($89.1M). IMRX YTD gains are higher at: 56.818 vs. ORMP (-9.917). ORMP has higher annual earnings (EBITDA): -21.53M vs. IMRX (-63.85M). ORMP has more cash in the bank: 131M vs. IMRX (35.9M). ORMP has less debt than IMRX: ORMP (301K) vs IMRX (4.08M). ORMP has higher revenues than IMRX: ORMP (2M) vs IMRX (0).
IMRXORMPIMRX / ORMP
Capitalization124M89.1M139%
EBITDA-63.85M-21.53M297%
Gain YTD56.818-9.917-573%
P/E RatioN/A20.91-
Revenue02M-
Total Cash35.9M131M27%
Total Debt4.08M301K1,356%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
53
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMRXORMP
RSI
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 5 days ago
82%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTTW15.250.10
+0.66%
Ottawa Bancorp, Inc.
LNNGF2.00N/A
N/A
Li Ning Co., Ltd.
LOQPF6.76N/A
N/A
Accesso Technology Group Plc
NCHEY12.10N/A
N/A
Nichirei Corp
CTGSP2.93N/A
N/A
Connecticut Natural Gas Corp.

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.93%
BTAI - ORMP
44%
Loosely correlated
N/A
INO - ORMP
44%
Loosely correlated
-37.85%
MBIO - ORMP
44%
Loosely correlated
N/A
VERV - ORMP
44%
Loosely correlated
N/A
ZNTL - ORMP
43%
Loosely correlated
N/A
More